What Does “Evidence-Based” Actually Mean?
“Evidence-based” is one of the most common phrases in healthcare. It is also one of the easiest to misunderstand.
It does not mean that every person receives the same treatment. It does not mean that a clinician follows a research paper without considering the patient in front of them. And it does not mean that an intervention is useless simply because a large trial has not yet been conducted.
Evidence-based care brings together three things: the best available research, clinical expertise, and the patient’s circumstances and preferences. The quality of the decision depends on how well those three are considered together.
Research tells us what is likely to help
Good research can show whether a treatment improves outcomes, how large the benefit may be, who was studied, and what harms occurred. It also helps us test ideas that sound convincing but do not produce meaningful results in people.
The details matter. Was there a comparison group? Were there enough participants? Did the researchers measure an outcome patients actually care about? Have other studies found similar results? A promising mechanism in a laboratory is a reason to investigate a treatment. It is not proof that the treatment works in clinical practice.
Research also has limits. A trial may exclude older patients, people taking several medicines, or those with multiple health conditions. The average result from that trial may be useful without predicting exactly what will happen for one individual.
Clinical expertise puts the evidence in context
A clinician must work out whether a study applies to the person seeking care. That includes reviewing the diagnosis, medical history, current treatments, possible interactions, practical barriers and signs that further investigation is needed.
Experience can help a clinician recognise patterns and tailor a plan. It cannot, by itself, establish that a treatment caused an improvement. Symptoms may fluctuate, other treatments may be acting at the same time, and people sometimes improve without the intervention being tested. Clinical observations can generate valuable questions; stronger research helps answer them.
The patient decides what matters
Two people with the same diagnosis may make different, reasonable choices. One may prioritise the largest likely benefit. Another may place greater weight on side effects, cost, convenience or a particular daily activity they want to regain.
A useful consultation makes those trade-offs visible. The question is not simply, “Does this treatment work?” It is, “How likely is it to help this person achieve their goal, what are the risks, and how will we know whether it was worthwhile?”
Evidence is a spectrum
Some treatments have consistent results from well-conducted studies and are supported by clinical guidelines. Others have encouraging early human data but still need larger trials. Some remain experimental, with most evidence coming from laboratory studies, animal models or a small number of cases.
Those differences should change how confidently we speak about a treatment. “Promising” is a reasonable description when early findings justify further study. It should not be presented as “proven.” Likewise, limited evidence should prompt an honest discussion of uncertainty, rather than an automatic dismissal of every possible use.
The strength of evidence can also differ by condition. A treatment studied for one problem does not inherit the same level of support when used for another.
What this means for your care
An evidence-based plan starts with a clear clinical question. We identify the outcomes that matter, compare the reasonable options, and consider safety and practicality. If we choose an intervention whose benefits remain uncertain, we say so. We agree on what to measure and when to review the result.
The aim is to make a well-informed decision for the individual, then remain willing to change course when better evidence or a clearer personal response becomes available.
Dr D. Michael Elliott, M.Sc., D.C., CFMP
